Overview
Certara combines predictive modeling, software, data science and strategic services across discovery, preclinical, clinical, regulatory and commercial development. Its services include modeling and simulation, biometrics, drug-development strategy, regulatory affairs, real-world evidence and market access, supported by products such as Simcyp, Phoenix, Pinnacle 21, GlobalSubmit, Certara.AI and CoAuthor. Certara reports more than 160,000 licensed software users, more than 2,600 life-sciences and academic customers, and use by 20 global drug regulatory agencies.